Johnson & Johnson (JNJ)
265.85
-2.19
(-0.82%)
USD |
NYSE |
Aug 31, 16:00
266.04
+0.19
(+0.07%)
After-Hours: 20:00
Johnson & Johnson Net Income (TTM) : 21.04B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 21.04B |
| March 31, 2026 | 21.04B |
| December 31, 2025 | 26.80B |
| September 30, 2025 | 25.12B |
| June 30, 2025 | 22.66B |
| March 31, 2025 | 21.81B |
| December 31, 2024 | 14.07B |
| September 30, 2024 | 14.77B |
| June 30, 2024 | 16.38B |
| March 31, 2024 | 17.07B |
| December 31, 2023 | 13.33B |
| September 30, 2023 | 12.42B |
| June 30, 2023 | 12.42B |
| March 31, 2023 | 11.86B |
| December 31, 2022 | 17.50B |
| September 30, 2022 | 19.01B |
| June 30, 2022 | 18.37B |
| March 31, 2022 | 19.83B |
| December 31, 2021 | 20.88B |
| September 30, 2021 | 17.88B |
| June 30, 2021 | 17.77B |
| March 31, 2021 | 15.12B |
| December 31, 2020 | 14.71B |
| September 30, 2020 | 16.99B |
| June 30, 2020 | 15.18B |
| Date | Value |
|---|---|
| March 31, 2020 | 17.17B |
| December 31, 2019 | 15.12B |
| September 30, 2019 | 14.15B |
| June 30, 2019 | 16.33B |
| March 31, 2019 | 14.68B |
| December 31, 2018 | 15.30B |
| September 30, 2018 | 1.542B |
| June 30, 2018 | 1.372B |
| March 31, 2018 | 1.245B |
| December 31, 2017 | 1.30B |
| September 30, 2017 | 15.83B |
| June 30, 2017 | 16.34B |
| March 31, 2017 | 16.50B |
| December 31, 2016 | 16.54B |
| September 30, 2016 | 15.94B |
| June 30, 2016 | 15.03B |
| March 31, 2016 | 15.55B |
| December 31, 2015 | 15.41B |
| September 30, 2015 | 14.72B |
| June 30, 2015 | 16.11B |
| March 31, 2015 | 15.92B |
| December 31, 2014 | 16.32B |
| September 30, 2014 | 17.32B |
| June 30, 2014 | 15.55B |
| March 31, 2014 | 15.06B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Eli Lilly & Co. | 26.71B |
| Merck & Co., Inc. | 3.169B |
| Pfizer Inc. | 4.373B |
| Bristol Myers Squibb Co. | 9.275B |
| Liquidia Corp. | 138.61M |